SALT LAKE CITY, March 31, 2014 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq:AMDA), a biomaterials company, today announced financial results for the fourth quarter and full year ended December 31, 2013.
Eric Olson, President and CEO of Amedica Corporation, said, “We have made substantial progress in moving the Company forward over the past year. Specifically, we increased our Silicon Nitride sales with the commercial launch of our Generation II Valeo interbody devices and brought others closer to market launch.
Help employers find you! Check out all the jobs and post your resume.
